Akros K-Humanoid Robot Top2 Plus Index
Korea’s pure-play humanoid robot exposure—builders and critical component suppliers powering the K-Humanoid ecosystem.
Sentiment Summary
Recent Events
A shareholder-allotment rights offering to raise approximately 200 billion KRW will have its ex-rights date on June 8, 2026. High price impact is expected due to significant share dilution, scheduled.
The ex-dividend date for the Q1 2026 dividend of KRW 2,500 is May 28, 2026, with payment scheduled for June 30, 2026; a low price impact of at least 1% is scheduled.
Hyundai Motor showcased its hydrogen ecosystem vision and the next-generation NEXO at the World Hydrogen Summit on May 21, 2026; a low price impact of at least 1% is expected.
Announced selection as a joint research institution for a national R&D project for an AI-based surgical robot, led by Yonsei Medical Center. The total project is worth approx. KRW 10 billion over 5 years.
CEO Cho Seong-hyun was awarded the 'Silver Tower Order of Industrial Service Merit' on 2026-05-20 for contributions to future mobility technologies like 'By-Wire' systems.
Announcement of an extraordinary general meeting on July 3, 2026, to add new business objectives including service robot operations; Low importance estimated due to limited immediate impact scheduled.
Announced a supply contract for humanoid robot precision reducers with a domestic robot manufacturer, valued at approximately 1.2 billion KRW (16.7% of recent annual sales). The contract period is from May 18, 2026, to April 29, 2028.
A block deal of 5 million shares (approx. 7.7% of total shares) related to a Price-Return Swap (PRS) contract was executed on May 19, 2026. The sale occurred at a discount, leading to a sharp decline in the stock price.